hydroxychloroquine has been researched along with Hepatitis C in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This review focuses on hepatic porphyrias, which include acute intermittent porphyria (AIP), variegate porphyria (VP), hereditary coproporphyria (HCP), aminolevulinic acid dehydratase deficiency porphyria (ADP), and porphyria cutanea tarda (PCT)." | 2.53 | Hepatic porphyria: A narrative review. ( Arora, S; Kodali, S; Singal, AK; Young, S, 2016) |
| "The novel coronavirus disease 2019 (COVID-19) is a highly infectious and rapidly spreading disease." | 1.56 | Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. ( Avdic, E; Avery, R; Cameron, AM; Chen, PH; Fine, DM; Garibaldi, B; Garneau, WM; Gurakar, A; Hammami, MB; Jain, T; Kim, AK; Liu, G; Monroy Trujillo, JM; Niranjan-Azadi, A; Petty, B; Shah, P; Strout, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Hammami, MB | 1 |
| Garibaldi, B | 1 |
| Shah, P | 1 |
| Liu, G | 1 |
| Jain, T | 1 |
| Chen, PH | 1 |
| Kim, AK | 1 |
| Avdic, E | 1 |
| Petty, B | 1 |
| Strout, S | 1 |
| Fine, DM | 1 |
| Niranjan-Azadi, A | 1 |
| Garneau, WM | 1 |
| Cameron, AM | 1 |
| Monroy Trujillo, JM | 1 |
| Gurakar, A | 1 |
| Avery, R | 1 |
| Khokhar, N | 1 |
| Arora, S | 1 |
| Young, S | 1 |
| Kodali, S | 1 |
| Singal, AK | 1 |
| Palazzi, C | 1 |
| D'Angelo, S | 1 |
| Olivieri, I | 1 |
| Tarwater, K | 1 |
| Misra, S | 1 |
| Misra, M | 1 |
| Grasset, D | 1 |
| Nougué, J | 1 |
| Seigneuric, C | 1 |
| Landreaud, M | 1 |
| Voigt, JJ | 1 |
| Doutre, MS | 1 |
| Beylot, C | 1 |
| Beylot-Barry, M | 1 |
| Dumas, F | 1 |
2 reviews available for hydroxychloroquine and Hepatitis C
| Article | Year |
|---|---|
Hepatic porphyria: A narrative review.
Topics: Acute Disease; Alcoholism; Biomarkers; Glucose; Hemin; Hemochromatosis; Hepatitis C; HIV Infections; | 2016 |
Hepatitis C virus-related arthritis.
Topics: Adrenal Cortex Hormones; Ankle; Antibodies, Viral; Arthralgia; Arthritis, Infectious; Arthritis, Rhe | 2008 |
5 other studies available for hydroxychloroquine and Hepatitis C
| Article | Year |
|---|---|
Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report.
Topics: Antibodies, Monoclonal, Humanized; Carcinoma, Hepatocellular; Coronavirus Infections; COVID-19; COVI | 2020 |
Development of Systemic Lupus Erythematosus Following Interferon-α Therapy for Hepatitis C Infection.
Topics: Adrenal Cortex Hormones; Female; Hepatitis C; Humans; Hydroxychloroquine; Immunologic Factors; Inter | 2016 |
Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report.
Topics: Enzyme Inhibitors; Female; Hepatitis C; Humans; Hydroxychloroquine; Kidney Failure, Chronic; Middle | 2008 |
[Porphyria cutanea tarda and chronic hepatitis C. Course after interferon therapy].
Topics: Adult; Hepatitis C; Hepatitis, Chronic; Humans; Hydroxychloroquine; Interferon-alpha; Male; Porphyri | 1994 |
[Hirsutism treated by estrogens and anti-estrogens: disclosure of porphyria cutanea tarda. Association with chronic hepatitis C].
Topics: Adult; Estrogen Antagonists; Female; Hepatitis C; Hepatitis, Chronic; Hirsutism; Humans; Hydroxychlo | 1994 |